Cara Therapeutics Stock News

Cara (CARA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Cara (CARA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nuveen Asset Management LLC trimmed its stake in shares of Cara Therapeutics Inc (NASDAQ:CARA) by 22.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Com

Cara Therapeutics Inc (NASDAQ:CARA) – Cantor Fitzgerald raised their FY2020 earnings per share (EPS) estimates for Cara Therapeutics in a research note issued to investors on Wednesday, April 22nd.

Zacks Investment Research upgraded shares of Cara Therapeutics (NASDAQ:CARA) from a hold rating to a buy rating in a research report released on Tuesday morning, Zacks.com reports. The firm currently

COVID-19’s spread has clamped down on a lot of economic activity, including the work of developing and testing new medicines. But the FDA isn’t showing

Cara Therapeutics Inc (NASDAQ:CARA) CEO Derek T. Chalmers sold 6,348 shares of the stock in a transaction that occurred on Tuesday, April 21st. The stock was sold at an average price of $15.56, for a

SKECHERS USA, Inc. (NYSE:SKX) reported first quarter 2020 earnings results today.

Cara Therapeutics Inc (NASDAQ:CARA) CEO Derek T. Chalmers sold 6,348 shares of Cara Therapeutics stock in a transaction dated Tuesday, April 21st. The shares were sold at an average price of $15.56, f

Cara Therapeutics price target raised to $34 from $26 at Cantor Fitzgerald Cantor Fitzgerald CARA

Cara Therapeutics Inc (NASDAQ:CARA) Director Jeffrey L. Ives sold 2,500 shares of the firm’s stock in a transaction dated Tuesday, April 21st. The shares were sold at an average price of $16.00, for

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Biohaven Pharmaceutical Holding Co (BHVN) and Cara

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Biohaven Pharmaceutical Holding Co ( BHVN – Research Report ) and Cara Therapeutics ( CARA – Resear